Biol stock forecast.

Precigen. Precigen is a synthetic biology company focused on developing the next generation of gene and cell therapies targeting immuno-oncology, autoimmune disorders, and infectious diseases. The ...Nov 13, 2023 · High Growth Earnings: BIOL is forecast to remain unprofitable over the next 3 years. Revenue vs Market: BIOL's revenue (10% per year) is forecast to grow faster than the US market (8% per year). High Growth Revenue: BIOL's revenue (10% per year) is forecast to grow slower than 20% per year. Stock Price Forecast. The 3 analysts offering 12-month price forecasts for BIOLASE Inc have a median target of 3.00, with a high estimate of 40.00 and a low estimate of 2.50. The median estimate represents a +143.90% increase from the last price of 1.23.Find the latest Gossamer Bio, Inc. (GOSS) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...4 equities research analysts have issued 1-year price objectives for Fortress Biotech's stock. Their FBIO share price targets range from $15.00 to $75.00. On average, they predict the company's stock price to reach $55.00 in the next year. This suggests a possible upside of 2,582.9% from the stock's current price.

Nov 27, 2023 · BIOLASE Stock Forecast and Price Target. The average price target for BIOLASE's stock set by recognized analysts recently is $21.50, which would result in a potential upside of approximately 1753.45% if it reached this mark. The estimation is based on a high estimate of $40.00 and a low estimate of $2.50. Competitors. Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Ideanomics Inc have a median target of 30,387.50, with a high estimate of 30,387.50 and a low estimate of ...

4 Wall Street research analysts have issued twelve-month price objectives for Ginkgo Bioworks' shares. Their DNA share price targets range from $1.25 to $3.00. On average, they anticipate the company's stock price to reach $2.25 in the next year. This suggests a possible upside of 58.5% from the stock's current price.

The current average BIOL price target, as estimated by these analysts, is $0.00. The predictions for the future BIOL stock price range from a low of $0.00 to a high of $0.00, highlighting the variability of market expectations for BIOL.BIOL Overview Stock Screener Earnings Calendar Sectors Nasdaq | BIOL U.S.: Nasdaq Biolase Inc. Watch list Set a price target alert After Hours Last Updated: Nov 24, 2023 4:47 p.m. EST...Based on 4 Wall Street analysts offering 12 month price targets for Tempest Therapeutics in the last 3 months. The average price target is $21.67 with a high forecast of $47.00 and a low forecast of $8.00. The average price target represents a 452.81% change from the last price of $3.92. Highest Price Target $47.00. Average Price Target $21.67.Find the latest Financials data for Biolase, Inc. Common Stock (BIOL) at Nasdaq.com.Nov 8, 2023 · Analyst projections state that BIOL is forecast to be at a low of $4.00 and a high of $40.00. In order for the stock price to hit the forecast high, the stock would need to plunge -2295.21% from its current level, while the stock would need to crash -139.52% from its current level to reach the projected low. Biolase Inc (BIOL) estimates and ...

Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. 3.29B. -13.94%. Get the latest Roche Holding AG (RO) real-time quote, historical ...

BIOL Stock. USD 0.08 0.0001 0.13%. BIOLASE stock price prediction is an act of determining the future value of BIOLASE shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of BIOLASE's future price could yield a significant profit.

Oct 15, 2020 · About the BIOLASE, Inc. stock forecast. As of 2023 November 18, Saturday current price of BIOL stock is 1.255$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception). Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile infection (CDI), overgrowth of pathogenic ...Find the latest Sonnet BioTherapeutics Holdings, Inc. (SONN) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook ...Maybe one or two of three stocks will fail, but those small losses are irrelevant if and when the third stock has a 1,000% return. Here's why Ontrak ( OTRK 3.67%) , Nano-X Imaging ( NNOX 14.20% ...Oct 15, 2020 · About the BIOLASE, Inc. stock forecast. As of 2023 November 18, Saturday current price of BIOL stock is 1.255$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception). DRRX Stock 12 Months Forecast. $8.50. (1187.88% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Durect in the last 3 months. The average price target is $8.50 with a high forecast of $8.50 and a low forecast of $8.50. The average price target represents a 1187.88% change from the last price of $0.66.

Find the latest ADMA Biologics, Inc. (ADMA) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...há 4 dias ... The BIOL share has a YTD performance of -22% and a 52-week price ... View real-time stock prices and stock quotes for a Robinhood Stock Price ...In 2023 so far, the iShares Biotechnology ETF (IBB) is down 7.5% while the S&P 500 is up more than 14%—but from 2012 to 2015, IBB beat the S&P 500 by more than 3-to-1. Picking the right biotech ...About the BIOLASE, Inc. stock forecast. As of 2023 November 18, Saturday current price of BIOL stock is 1.255$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).Find real-time BLUE - bluebird bio Inc stock quotes, company profile, news and forecasts from CNN Business.

The current average BIOL price target, as estimated by these analysts, is $0.00. The predictions for the future BIOL stock price range from a low of $0.00 to a high of $0.00, highlighting the variability of market expectations for BIOL.

BIOLASE (NASDAQ:BIOL) on Wednesday said it would effect a 1-for-100 reverse stock split.The company's common stock will begin trading on a split-adjusted basis on July 28. "The primary purpose of ...Find real-time AITX - Artificial Intelligence Technology Solutions Inc stock quotes, company profile, news and forecasts from CNN Business.BIOL Stock. USD 0.08 0.0001 0.13%. BIOLASE stock price prediction is an act of determining the future value of BIOLASE shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of BIOLASE's future price could yield a significant profit. BIOLASE Inc (BIOL) Stock Price & News - Google Finance Markets Home BIOL • NASDAQ BIOLASE Inc Follow Share $1.22 After Hours: $1.25 (2.79%) +0.034 Closed: Nov 24, 3:59:26 PM GMT-5 · USD ·...Quotes Summary Real-Time After-Hours Key Data Bid Price and Ask Price The bid & ask refers to the price that an investor is willing to buy or sell a stock. The bid is the highest …Track Biolase Inc (BIOL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors. Join the Conversation! Build your trading network; Follow your favorite assets ...52,938.42. -121.12. -0.23%. NBI | A complete Nasdaq Biotechnology Index index overview by MarketWatch. View stock market news, stock market data and trading information.The value each BIOL share was expected to gain vs. the value that each BIOL share actually gained. BIOLASE ( BIOL) reported Q2 2023 earnings per share (EPS) of -$8.93, missing estimates of -$5.33 by 67.48%. In the same quarter last year, BIOLASE 's earnings per share (EPS) was -$90.62. BIOLASE is expected to release next earnings on -, with an ... Based on analysts offering 12 month price targets for BIOL in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .

The Clean Vision Corporation stock price fell by -6.75% on the last day (Friday, 1st Dec 2023) from $0.0467 to $0.0436. During the last trading day the stock fluctuated 15.38% from a day low at $0.0416 to a day high of $0.0480. The price has fallen in 6 of the last 10 days and is down by -7.34% for this period.

BIOL stock forecast Our latest prediction for Biolase Inc's stock price was made on the Nov. 30, 2021 when the stock price was at 0.44$. In the short term (2weeks), BIOL's stock price should outperform the market by 2.41%. During that period the price should oscillate between -11.17% and +18.16%.

16 equities research analysts have issued 12 month price objectives for AbbVie's stock. Their ABBV share price targets range from $150.00 to $196.00. On average, they anticipate the company's stock price to reach $167.94 in the next year. This suggests a possible upside of 17.1% from the stock's current price.Bank of America Corp. analyst ratings, historical stock prices, earnings estimates & actuals. BAC updated stock price target summary.If you are thinking about buying BIOL, make sure you check out the free BIOL stock predictions report provided by MarketClub. They use their proprietary Smart Scan and Trade Triangle technology to analyze the stock and you will get an instant report on how BIOL will perform in the near future. You will get a free BIOL forecast report will be ...Stock Symbol. BIOL. Stock Symbol. Investments. 1. Share Price. $1.25; (As of Friday Closing). Biolase General Information. Description. Biolase Inc is a US- ...BIOLASE is the world’s leading innovator in dental lasers. Our state-of-the-art dental lasers deliver unparalleled precision, efficiency, and patient comfort with minimally invasive solutions for optimal outcomes. Experience the BIOLASE difference and discover the limitless potential of laser dentistry. Dentists.Dec 1, 2023 · See the latest Biolase Inc stock price (BIOL:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Q4 revenues are expected to be in a range of $12.2 million to $12.5 million, well above consensus expectations of $10.7 million and up approximately 30% sequentially and 45% year-over-year ...Nov 13, 2023 · High Growth Earnings: BIOL is forecast to remain unprofitable over the next 3 years. Revenue vs Market: BIOL's revenue (10% per year) is forecast to grow faster than the US market (8% per year). High Growth Revenue: BIOL's revenue (10% per year) is forecast to grow slower than 20% per year. Biolase price target lowered to $3.00 from $5.00 at Maxim November 15, 2023TipRanks. Positive Clinical Trial Results and Successful Cost Optimization Initiatives Bolster Buy Rating for Biolase ...Looking at the chart of Biolase Inc. (BIOL Stock Forecast), we can see a starkly different trend in comparison to the AMPE stock chart. Sure, this year has been relatively flat. But pull out a 2-year chart and you’ll see that BIOL stock has been in a perpetual downtrend since last March.

Read Full Company Summary for BIOL here. View Biolase, Inc BIOL investment & stock information. Get the latest Biolase, Inc BIOL detailed stock quotes, stock data, Real-Time ECN, charts, stats and ...Based on 3 Wall Street analysts offering 12 month price targets for American Superconductor in the last 3 months. The average price target is $15.67 with a high forecast of $23.00 and a low forecast of $10.00. The average price target represents a 102.19% change from the last price of $7.75. Highest Price Target $23.00.Find the latest BioElectronics Corporation (BIEL) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ...Instagram:https://instagram. kandi carcxi exchangemorgan stanley ratingactive care plus banfield cost It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ...Find the latest Sana Biotechnology, Inc. (SANA) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ... benefits of wyoming llclive cattle futures chart The Biolase Inc (BIOL) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $21.75, representing a +1,639% increase from the current price of $1.2506. The highest analyst price target is $42.41, and the lowest is $1.0934. how much is a gold ingot worth today Stock Price Forecast. According to 3 stock analysts, the average 12-month stock price forecast for BIOLASE stock is $113.33, which predicts an increase …1 equities research analysts have issued 1 year price targets for Cassava Sciences' shares. Their SAVA share price targets range from $11.00 to $124.00. On average, they predict the company's share price to reach $54.33 in the next year. This suggests a possible upside of 154.5% from the stock's current price.Based on 5 Wall Street analysts offering 12 month price targets for Cleanspark in the last 3 months. The average price target is $9.16 with a high forecast of $14.00 and a low forecast of $5.30. The average price target represents a 123.96% change from the last price of $4.09. Highest Price Target $14.00. Average Price Target $9.16.